REFERENCES
- Golper T. A., Bennett W. M. Drug Removal by Continuous Arteriovenous Haemofiltration. Med. Toxicol. 1988; 3: 341–349
- Amdisen A. Clinical Features and Management of Lithium Poisoning. Med. Toxicol. 1988; 3: 18–32
- Ellenhorn M. J., Barceloux D. G. Lithium. Medical Toxicology: Diagnosis and Treatment of Human Poisoning. ElselvierScience Publishing Company. 1988; 1042–1045
- Schou M. Lithium Studies. 3. Distribution Between Serum and Tissues. Acta Pharmacol. Toxicol. 1958; 15: 115–124
- Newman P. K., Saunders M. Lithium Neurotoxicity. Postgrad. Med. J. 1979; 55: 701–703
- Sansone M. E.G, Ziegler D. K. Lithium Toxicity: A Review of Neurologic Complications. Clin. Neuropharmacol. 1985; 8: 242–248
- Clendeninn N. J., Pond S. M., Kaysen G., Barraza J. J., Farrell T., Becker C. E. Potential Pitfalls in the Evaluation of the Usefulness of Hemodialysisfor the Removal of Lithium. J. Toxicol. Clin. Toxicol. 1982; 19: 341–352
- Jaeger A., Sauder P., Kopferschmitt J., Jaegle M. L. Toxicokinetics of Lithium Intoxication Treated by Hemodialysis. J. Toxicol. Clin. Toxicol. 1985–1986; 23: 501–517
- Thomsen K., Schou M. Renal Lithium Excretion in Man. Am. J. Physiol. 1968; 215: 823–827
- Imbs J. L., Barthelmebs M., Danion J. M., Singer L. Mechanisms of Drug Interactions with Renal Elimination of Lithium. Bull. Acad. Natl. Med. 1997; 181: 685–695
- Finley P. R., O'Brien J. G., Coleman R. W. Lithium and Angiotensin Converting Enzyne Inhibitors: Evaluationof a Potential Interaction. J. Clin. Psychopharmacol. 1996; 16: 68–71
- Cockroft D. W., Gault M. H. Prediction of Creatinine Clearance from Serum Creatinine. Nephron 1976; 16: 31–41
- Jacobsen D., Aasen G., Frederichsen P., Eisenga B. Lithium Intoxication: Pharmacokinetics During and After TerminatedHaemodialysis in Acute Intoxications. J. Toxicol. Clin. Toxicol. 1987; 25: 81–94
- Sigler M. H., Teehan B P., Van Calkenburgh D. Solute Transport in Continuous Haemodialysis: A New Treatmentfor Acute Renal Failure. Kid. Int. 1987; 32: 562–571
- Kronfol N., Lau A., Colon-Rivera J., Libertin C. Effect of CAVH Membrane Types on Drugs Sieving Coefficients(SC) and Clearances (CL). A.S.A.I.O. 1986; 15
- Kronfol N. O., Adams L. J., Powell S. S., Lau A. H. Drug Removal. ContinuousArteriovenous Haemodialysis (CAVHD). Abstracts ASN 1988. National Kidney Foundation18th Ann. Sci. Meet.
- Gatell A. A., Regidor M. A.L., Saura J. M., Boladeras R. M.D., Calvera J. M.S., Panades M. N. Intoxication Aguda pr Litio. Tratamiento con HemofiltracionArteriovenosa Continua. A Proposito de un Caso. Rev. Clin. Esp. 1989; 185: 195–197
- Hazouard E., Ferrandiere M., Rateau H., Doucet O., Perrotin D., Legras A. Continuous Veno-venous Haemofiltration versus Continuous Veno-venousHaemodialysis in Severe Lithium Self Poisoning: A Toxicokinetics Study inan Intensive Care Unit. Nephrol. Dial. Transplant. 1999; 14: 1605–1606
- Leblanc M., Raymond M., Bonnardeaux A., Isenring P., Pichette V., Geadah D., Ouimet D., Ethier J., Cardinal J. Lithium Poisoning Treated by High Performance Continuous Arteriovenousand Venovenous Hemodiafiltration. Am. J. Kid. Dis. 1996; 27: 365–372
- Bellomo R., Ronco C. Continuous Renal Replacement Therapy in the Intensive Care Unit. Intensive Care Med. 1999; 25: 781–789